Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_assertion type Assertion NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_head.
- NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_assertion description "[The aberrant expression of KLKs, presented in many human malignancies, highlights the significance of this gene family for early diagnosis, prognosis and monitoring of cancer patients, as it is strongly emphasized by the routine use of PSA (KLK3) for prostate cancer management.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_provenance.
- NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_assertion evidence source_evidence_literature NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_provenance.
- NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_assertion SIO_000772 20302518 NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_provenance.
- NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_assertion wasDerivedFrom befree-2016 NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_provenance.
- NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_assertion wasGeneratedBy ECO_0000203 NP801058.RA764ZcUvvi6FluhZOEvgSrj2MysmXIqRaV49BPv14Q3Q130_provenance.